THE PANDEMIC INFLUENCE TO FIRM SIZE AND FINANCIAL RATIO ON LISTED COMPANIES IN THE HEALTHCARE INDUSTRY

  • Rani Ramdhani Management Department, BINUS Business School Undergraduate Program, Bina Nusantara University
  • Mulyono Mulyono Management Department, BINUS Business School Undergraduate Program, Bina Nusantara University
  • Respati Wulandari Business Creation, BINUS Business School Undergraduate Program, Bina Nusantara University
DOI: https://doi.org/10.31937/manajemen.v15i2.3381

Abstract

Abstract - During the pandemic, the government enacted policies that restricted people's travel, impacting corporate development across the board. The study's goal is to analyze the influence of the pandemic on firm size and financial ratios of companies listed on the Indonesia Stock Exchange in the Healthcare industry. Market capitalization statistics, return on assets, and debt to equity ratios were used as study samples. To assess the research hypothesis, the Wilcoxon sign rank test was performed. According to the findings of the study, return on assets decreased significantly during the pandemic, debt to equity ratio remained stable and did not vary significantly, and company size increased significantly during the pandemic. Companies in the post-pandemic period must pay close attention to the proper composition of funding sources in order to boost profitability and gain the trust of investors.

Keywords: Debt to Equity; Financial Ratio; Firm Size; Pandemic Covid-19; Return on Asset

Downloads

Download data is not yet available.
Published
2023-12-31
How to Cite
Ramdhani, R., Mulyono, M., & Wulandari, R. (2023). THE PANDEMIC INFLUENCE TO FIRM SIZE AND FINANCIAL RATIO ON LISTED COMPANIES IN THE HEALTHCARE INDUSTRY. Ultima Management : Jurnal Ilmu Manajemen, 15(2), 266-273. https://doi.org/https://doi.org/10.31937/manajemen.v15i2.3381
Issue
Vol 15 No 2 (2023): Ultima Management : Jurnal Ilmu Manajemen
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike International License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.